These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16873551)

  • 1. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.
    Kannankeril PJ; Mitchell BM; Goonasekera SA; Chelu MG; Zhang W; Sood S; Kearney DL; Danila CI; De Biasi M; Wehrens XH; Pautler RG; Roden DM; Taffet GE; Dirksen RT; Anderson ME; Hamilton SL
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12179-84. PubMed ID: 16873551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pan X; Philippen L; Lahiri SK; Lee C; Park SH; Word TA; Li N; Jarrett KE; Gupta R; Reynolds JO; Lin J; Bao G; Lagor WR; Wehrens XHT
    Circ Res; 2018 Sep; 123(8):953-963. PubMed ID: 30355031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden infant death syndrome in mice with an inherited mutation in RyR2.
    Mathur N; Sood S; Wang S; van Oort RJ; Sarma S; Li N; Skapura DG; Bayle JH; Valderrábano M; Wehrens XH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):677-85. PubMed ID: 20009080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.
    Jiang D; Wang R; Xiao B; Kong H; Hunt DJ; Choi P; Zhang L; Chen SR
    Circ Res; 2005 Nov; 97(11):1173-81. PubMed ID: 16239587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
    J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
    Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Cerrone M; Noujaim SF; Tolkacheva EG; Talkachou A; O'Connell R; Berenfeld O; Anumonwo J; Pandit SV; Vikstrom K; Napolitano C; Priori SG; Jalife J
    Circ Res; 2007 Nov; 101(10):1039-48. PubMed ID: 17872467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    Paavola J; Viitasalo M; Laitinen-Forsblom PJ; Pasternack M; Swan H; Tikkanen I; Toivonen L; Kontula K; Laine M
    Eur Heart J; 2007 May; 28(9):1135-42. PubMed ID: 17347175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs.
    Li N; Wang Q; Sibrian-Vazquez M; Klipp RC; Reynolds JO; Word TA; Scott L; Salama G; Strongin RM; Abramson JJ; Wehrens XHT
    Int J Cardiol; 2017 Jan; 227():668-673. PubMed ID: 27838126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A knock-in mouse model of N-terminal R420W mutation of cardiac ryanodine receptor exhibits arrhythmogenesis with abnormal calcium dynamics in cardiomyocytes.
    Okudaira N; Kuwahara M; Hirata Y; Oku Y; Nishio H
    Biochem Biophys Res Commun; 2014 Sep; 452(3):665-8. PubMed ID: 25193700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation-linked defective interdomain interactions within ryanodine receptor cause aberrant Ca²⁺release leading to catecholaminergic polymorphic ventricular tachycardia.
    Suetomi T; Yano M; Uchinoumi H; Fukuda M; Hino A; Ono M; Xu X; Tateishi H; Okuda S; Doi M; Kobayashi S; Ikeda Y; Yamamoto T; Ikemoto N; Matsuzaki M
    Circulation; 2011 Aug; 124(6):682-94. PubMed ID: 21768539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
    Liu N; Colombi B; Memmi M; Zissimopoulos S; Rizzi N; Negri S; Imbriani M; Napolitano C; Lai FA; Priori SG
    Circ Res; 2006 Aug; 99(3):292-8. PubMed ID: 16825580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.
    Cerrone M; Colombi B; Santoro M; di Barletta MR; Scelsi M; Villani L; Napolitano C; Priori SG
    Circ Res; 2005 May; 96(10):e77-82. PubMed ID: 15890976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of cardiac ryanodine receptor protects against stress-induced ventricular tachyarrhythmia, but increases the susceptibility to cardiac alternans.
    Zhong X; Vallmitjana A; Sun B; Xiao Z; Guo W; Wei J; Ni M; Chen Y; O'Brien ER; Gillis AM; Hoshijima M; Takeshima H; Hove-Madsen L; Benitez R; Belke D; Wayne Chen SR
    Biochem J; 2018 Jan; 475(1):169-183. PubMed ID: 29170159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.
    George CH; Higgs GV; Lai FA
    Circ Res; 2003 Sep; 93(6):531-40. PubMed ID: 12919952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
    Jiang D; Xiao B; Zhang L; Chen SR
    Circ Res; 2002 Aug; 91(3):218-25. PubMed ID: 12169647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.